Evidence map›Paper›PMID 34859420›Full record

ArticleBritish journal of haematology2022

Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia.

Amina Nardo-Marino, Jesper Petersen, John N Brewin, Henrik Birgens, Thomas N Williams, Jørgen A L Kurtzhals, David C Rees, Andreas Glenthøj

Open access · hybridAbstract read
In one paragraph

Article in British journal of haematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Amina Nardo-MarinoDepartment of Haematology, Centre for Haemoglobinopathies, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.ORCID 0000-0001-5256-7330
Jesper PetersenDepartment of Haematology, Centre for Haemoglobinopathies, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.ORCID 0000-0001-6116-5114
John N BrewinDepartment of Haematological Medicine, King's College Hospital, London, United Kingdom.ORCID 0000-0002-6129-4300
Henrik BirgensDepartment of Haematology, Centre for Haemoglobinopathies, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
Thomas N WilliamsKEMRI/Wellcome Trust Research Programme, Kilifi, Kenya.
Jørgen A L KurtzhalsDepartment of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-2760-8713
David C ReesDepartment of Haematological Medicine, King's College Hospital, London, United Kingdom.ORCID 0000-0003-3647-1050
Andreas GlenthøjDepartment of Haematology, Centre for Haemoglobinopathies, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.ORCID 0000-0003-2082-0738
Copenhagen University Hospital · DKKing's College London · GBUniversity of Copenhagen · DKKenya Medical Research Institute · KE

Funding

Wellcome Trust 202800/Z/16/ZWellcome Trust 203077
6 · The paper itself

Abstract

The loss of red blood cell (RBC) deformability in sickle cell anaemia (SCA) is considered the primary factor responsible for episodes of acute pain and downstream progressive organ dysfunction. Oxygen gradient ektacytometry (Oxygenscan) is a recently commercialised functional assay that aims to describe the deformability of RBCs in SCA at differing oxygen tensions. So far, the Oxygenscan has been evaluated only by a small number of research groups and the validity and clinical value of Oxygenscan-derived biomarkers have not yet been fully established. In this study we examined RBC deformability measured with the Oxygenscan in 91 children with SCA at King's College Hospital in London. We found a significant correlation between Oxygenscan-derived biomarkers and well-recognised modifiers of disease severity in SCA: haemoglobin F and co-inherited α-thalassaemia. We failed, however, to find any independent predictive value of the Oxygenscan in the clinical outcome measure of pain, as well as other important parameters such as hydroxycarbamide treatment. Although the Oxygenscan remains an intriguing tool for basic research, our results question whether it provides any additional information in predicting the clinical course in children with SCA, beyond measuring known markers of disease severity.

Indexed as

Anemia, Sickle CellOxygenBiomarkersChildErythrocyte DeformabilityHumansPainBiomarkersOxygenclinical trialshydroxycarbamidered blood cell deformabilitysickle cell anaemiaα-thalassaemia

Identifiers

PMID34859420
PMCPMC7613550
OpenAlexW3217281256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.